FDA Expands Approval for RSV Vaccine, Now Available for Adults Over 50

The Food and Drug Administration (FDA) has recently approved an expansion of a respiratory syncytial virus (RSV) vaccine for use in at-risk adults over the age of 50. The post FDA Expands Approval for RSV Vaccine, Now Available for Adults Over 50 appeared first on The Gateway Pundit. Read More in The Gateway Pundit.   Read More in Red Pill NOWlej.